Bone Metastases in Renal Cell Carcinoma: Impact of Immunotherapy on Survival.

Gambale, Elisabetta; Palmieri, Valeria Emma; Rossi, Virginia; Francini, Edoardo; Bonato, Adele; Salfi, Alessia; Galli, Luca; Mela, Marinella Micol; Pillozzi, Serena; Antonuzzo, Lorenzo

Gambale, Elisabetta; Palmieri, Valeria Emma; Rossi, Virginia; Francini, Edoardo; Bonato, Adele; Salfi, Alessia; Galli, Luca; Mela, Marinella Micol; Pillozzi, Serena; Antonuzzo, Lorenzo.

Afiliação

Gambale E; Clinical Oncology Unit, Careggi University Hospital, Florence, Italy.
Palmieri VE; Sandro Pitigliani Medical Oncology Department, Hospital of Prato, Prato, Italy.
Rossi V; Clinical Oncology Unit, Careggi University Hospital, Florence, Italy.
Francini E; Clinical Oncology Unit, Careggi University Hospital, Florence, Italy.
Bonato A; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Salfi A; Medical Oncology Unit 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
Galli L; Medical Oncology Unit 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
Mela MM; Medical Oncology Unit 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
Pillozzi S; Clinical Oncology Unit, Careggi University Hospital, Florence, Italy.
Antonuzzo L; Clinical Oncology Unit, Careggi University Hospital, Florence, Italy.

Cancer Diagn Progn ; 3(5): 538-542, 2023.

Article em En | MEDLINE | ID: mdl-37671314

Palavras-chave

Immunotherapy; bone metastases; overall survival; renal cell cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google